Q32 Bio stockholders approve officer exculpation charter amendment at 2025 annual meeting

Q32 Bio Inc.

Charter amendment limiting officer liability (Delaware law) approved; effective June 16, 2025.
David Grayzel, Isaac Manke, and Diyong Xu elected Class I directors for three-year terms.
Ernst & Young ratified as independent auditor for FY 2025 with 99.9% votes for.
Say-on-pay advisory vote passed with 7.45M for; one-year frequency selected for future votes.
Adjournment proposal also approved (7.88M for) but not needed as Proposal 2 passed.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Q32 Bio Inc.: Approved amendment to Restated Certificate of Incorporation to limit liability of certain officers as permitted by Delaware law (effective 2025-06-16).

Change: charter amendment
Effective: 2025-06-16

Exact text from the filing

on June 13, 2025 at the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Q32 Bio Inc. (the “Company”), and upon the recommendation of the Board of Directors (the “Board”) of the Company, the Company’s stockholders approved an amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”) to limit the liability of certain officers of the Company as permitted by Delaware law (the “Charter Amendment”).

View on SEC.gov

Browse all governance changes →

Q32 Bio Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-142039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.